Optipharm.CO.,LTD Statistics

Total Valuation

KOSDAQ:153710 has a market cap or net worth of KRW 76.58 billion. The enterprise value is 76.41 billion.

Market Cap	76.58B
Enterprise Value	76.41B

Important Dates

Earnings Date	n/a
Ex-Dividend Date	n/a

Share Statistics

KOSDAQ:153710 has 14.67 million shares outstanding. The number of shares has increased by 0.13% in one year.

Current Share Class	14.67M
Shares Outstanding	14.67M
Shares Change (YoY)	+0.13%
Shares Change (QoQ)	+0.81%
Owned by Insiders (%)	6.74%
Owned by Institutions (%)	n/a
Float	8.61M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	3.48
PB Ratio	2.98
P/TBV Ratio	3.01
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-32.03
EV / Sales	3.48
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-19.26

Financial Position

The company has a current ratio of 1.29, with a Debt / Equity ratio of 0.41.

Current Ratio	1.29
Quick Ratio	1.01
Debt / Equity	0.41
Debt / EBITDA	n/a
Debt / FCF	-2.67
Interest Coverage	-4.55

Financial Efficiency

Return on equity (ROE) is -9.71% and return on invested capital (ROIC) is -4.13%.

Return on Equity (ROE)	-9.71%
Return on Assets (ROA)	-3.59%
Return on Invested Capital (ROIC)	-4.13%
Return on Capital Employed (ROCE)	-8.03%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.54
Inventory Turnover	9.65

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +10.71% in the last 52 weeks. The beta is -0.27, so KOSDAQ:153710's price volatility has been lower than the market average.

Beta (5Y)	-0.27
52-Week Price Change	+10.71%
50-Day Moving Average	5,054.50
200-Day Moving Average	5,183.78
Relative Strength Index (RSI)	50.93
Average Volume (20 Days)	77,551

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, KOSDAQ:153710 had revenue of KRW 21.98 billion and -2.39 billion in losses. Loss per share was -162.63.

Revenue	21.98B
Gross Profit	5.67B
Operating Income	-2.34B
Pretax Income	-2.39B
Net Income	-2.39B
EBITDA	-676.63M
EBIT	-2.34B
Loss Per Share	-162.63

Full Income Statement

Balance Sheet

The company has 10.76 billion in cash and 10.59 billion in debt, giving a net cash position of 170.73 million or 11.64 per share.

Cash & Cash Equivalents	10.76B
Total Debt	10.59B
Net Cash	170.73M
Net Cash Per Share	11.64
Equity (Book Value)	25.71B
Book Value Per Share	1,738.31
Working Capital	3.74B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -973.93 million and capital expenditures -2.99 billion, giving a free cash flow of -3.97 billion.

Operating Cash Flow	-973.93M
Capital Expenditures	-2.99B
Free Cash Flow	-3.97B
FCF Per Share	-270.46

Full Cash Flow Statement

Margins

Gross margin is 25.78%, with operating and profit margins of -10.66% and -10.85%.

Gross Margin	25.78%
Operating Margin	-10.66%
Pretax Margin	-10.85%
Profit Margin	-10.85%
EBITDA Margin	-3.08%
EBIT Margin	-10.66%
FCF Margin	n/a

Dividends & Yields

KOSDAQ:153710 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.13%
Shareholder Yield	-0.13%
Earnings Yield	-3.11%
FCF Yield	-5.18%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

KOSDAQ:153710 has an Altman Z-Score of 2.17 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.17
Piotroski F-Score	3